Brazil adds 95,601 new cases of Covid-19, the highest number since March (June 2)

RIO DE JANEIRO, BRAZIL – Brazil, one of the countries most affected by the coronavirus globally, added on Wednesday 95,601 new covid-19 infections, the highest number since March, and 2,507 deaths due to the disease, according to data from the Ministry of Health.

The bulletin released by the Ministry of Health states that the country accumulates 16,720,081 confirmed cases and 467,706 deaths linked to the coronavirus.

The 95,601 reported positives are the highest figure since March 25, when 100,158 infected persons were reported, a historical record since the outbreak of SARS-CoV-2.

The figures confirm the country of some 212 million inhabitants as the country with the second-highest number of deaths globally, behind the United States, and the third with the third-highest number of infections, after the USA and India.

While the daily average of deaths has stabilized at a level below 2,000 for the last two weeks, Brazil is experiencing an upturn in infections, with an average of 61,467 new cases per day, compared to the average of 60,276 recorded a month ago.

The increase in infections occurs in the midst of a greater relaxation of restrictions by the states, which has triggered the scientific community’s alerts, which foresees the arrival of a third wave in the coming weeks.

According to the Health Ministry, 90.7% of those infected have recovered from the coronavirus in the country (15,168,330 people), while another 1,084,045 are still under medical care.

Brazil sees the advance of mass vaccination of its population as the best weapon to control the pandemic. However, so far, little more than 22% of Brazilians have received the first dose of any of the formulas used in the country.

However, the authorities rely on a faster pace of local vaccine production to accelerate the immunization process in the coming weeks.

In this sense, the Oswaldo Cruz Foundation (Fiocruz) announced today the arrival of the stem cell banks and the virus that will allow the production of the AstraZeneca vaccine with total autonomy in Brazil, one day after it signed a technology transfer agreement to manufacture the Anglo-Swedish laboratory’s drug locally.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error